Federal Ministry of Finance (Germany)

DGAP-News: Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022

Retrieved on: 
Tuesday, July 12, 2022
Income, BCMA, Achievement, AACR, Safety, August Faller GmbH & Co. KG, Federal Ministry of Finance (Germany), Federal Ministry for Economic Affairs and Energy, FSE, Spanish mythology, Telix, Federal Financial Supervisory Authority, Therapy, American Association, ADC, Patient, CEO, Phase, Medicine, Economy, COVID-19, Kidney, Redhill, Multiple myeloma, Federal, Huadong Medicine, HPHA, CFO, Lymphatic system, Depreciation, Association, Gesellschaft mit beschränkter Haftung, Annual general meeting, Partnership, NASDAQ, Security (finance), Fine chemical, Pharmaceutical industry

Dr. Jan Schmidt-Brand, CEO and CFO of Heidelberg Pharma AG, commented: "We are looking back on an exceptionally successful first half of the year.

Key Points: 
  • Dr. Jan Schmidt-Brand, CEO and CFO of Heidelberg Pharma AG, commented: "We are looking back on an exceptionally successful first half of the year.
  • The Heidelberg Pharma Group (Heidelberg Pharma) comprising Heidelberg Pharma AG and its subsidiary Heidelberg Pharma Research GmbH reports consolidated figures.
  • The net loss posted by the Heidelberg Pharma Group for the first six months of 2022 came to EUR8.6 million (previous year: EUR13.1 million).
  • In this respect, the full-year financial guidance issued on 24 March 2022 for the Heidelberg Pharma Group will not be adjusted at this time.

DGAP-News: SGT German Private Equity GmbH & Co. KGaA: Closing of the first Private Equity transaction and first close of the Private Equity Fund

Retrieved on: 
Tuesday, June 7, 2022
German Startups Group, SGF, Business, Private-equity fund, Partner, Committee, University, EQT, CFIUS, Technology, Acquisition, Energy, SGT, Federal Ministry of Finance (Germany), Christoph Gerlinger, Â, Foreign investment, Private equity, Capital Dynamics, Committee on Foreign Investment in the United States, Human resource policies, Economy, Running, Security (finance), Financial services, Bank, Commonfund, Sophos

DGAP-News: SGT German Private Equity GmbH & Co. KGaA

Key Points: 
  • DGAP-News: SGT German Private Equity GmbH & Co. KGaA
    SGT German Private Equity GmbH & Co. KGaA: Closing of the first Private Equity transaction and first close of the Private Equity Fund
    The issuer is solely responsible for the content of this announcement.
  • Frankfurt/Main, 1 June 2022 SGT German Private Equity GmbH & Co. KGaA (SGF), a listed Private Equity asset manager, announces the closing of the first Private Equity transaction of its wholly owned subsidiary SGT Capital Pte.
  • Christoph Gerlinger, Managing Director of SGT German Private Equity and Partner of SGT Capital, adds: With the closing, the transformation of the former German Startups Group into a Germany-based Private Equity asset manager under the name SGT German Private Equity is completed and moves from the preparation stage into operations.
  • SGT German Private Equity is a Germany-based listed private equity asset manager with registered office in Frankfurt/Main.

DGAP-News: Biotest AG: Biotest records sales of € 115 million in the first quarter of 2022

Retrieved on: 
Thursday, May 5, 2022
Process performance qualification protocol, Board, Saskatchewan River Sturgeon Management Board, Tax, Grifols, Education, EBIT, COVID-19, Federal Ministry of Education and Research (Germany), Patient, Next Level, S.A, Antibody, PPI, Federal Ministry of Finance (Germany), III, Annual report, Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science, Achievement, Forschungs- und Arbeitsgemeinschaft Irland e.V., Management, Annual general meeting, Technology, Speech, Community-acquired pneumonia, Acquisition, Video game, Pharmaceutical industry, Health, Research

The Biotest Group recorded revenue of 115.9 million in the first quarter of 2022.

Key Points: 
  • The Biotest Group recorded revenue of 115.9 million in the first quarter of 2022.
  • EBIT for the first quarter of 2022 amounted to -5.0 million and was thus significantly above the previous years figure (same period of the previous year: -9.3 million).
  • The increase in EBIT compared to the first quarter of 2021 is mainly due to the 3.2 million increase in gross profit.
  • The Biotest Groups result after taxes for the first quarter of 2022 increased to -4.9 million after -14.1 million in the same quarter of the previous year.

DGAP-News: Engel & Völkers Digital Invest sets final offer price for IPO at 14.00 Euro per share

Retrieved on: 
Wednesday, April 27, 2022
Federal Ministry of Finance (Germany), Frankfurt Stock Exchange, IPO, THIS, Growth, AMERICA, Company, WKN, ISIN, THE, Security (finance), Bank

EV Digital Invest AG ("Company" and together with its subsidiary, "Engel & Vlkers Digital Invest"), operator of the online real estate investment platform "Engel & Vlkers Digital Invest", has set the final offer price in the IPO at 14.00 Euro per offer share.

Key Points: 
  • EV Digital Invest AG ("Company" and together with its subsidiary, "Engel & Vlkers Digital Invest"), operator of the online real estate investment platform "Engel & Vlkers Digital Invest", has set the final offer price in the IPO at 14.00 Euro per offer share.
  • At the offer price, the IPO of Engel & Vlkers Digital Invest was oversubscribed.
  • Engel & Vlkers Digital Invest plans to use the net issue proceeds from the IPO to finance its dynamic growth.
  • The fast-growing digital investment platform for real estate "Engel & Vlkers Digital Invest" offers private investors the opportunity to participate in selected real estate projects as co-investors.

DGAP-News: MIG Capital continues to grow after excellent financial year 2021

Retrieved on: 
Wednesday, April 27, 2022
MIG, Parkinson's disease, German, Gottfried Wilhelm Leibniz, Research, VC, Federal Financial Supervisory Authority, LRZ, University of the German Federal Armed Forces, Bavarian Academy of Sciences and Humanities, Machine learning, Program, Sale, Artificial intelligence, Silicon carbide, General partnership, Federal Ministry of Finance (Germany), Growth, Science, Precision medicine, Technology, IQM, MicroPort, Hypercholesterolemia, Investment, Semiconductor, Education, Quantum, Therapy, Lawyer, Security (finance), Renewable energy, Financial services, Fine chemical, Infineon Technologies, BRAIN, BioNTech

Numerous MIG investors participated in the tremendous success of this company via MIG funds and were among the first investors in BioNTech.

Key Points: 
  • Numerous MIG investors participated in the tremendous success of this company via MIG funds and were among the first investors in BioNTech.
  • During the 2021 fiscal year, MIG Capital AG added new, highly innovative companies to its portfolio of managed funds:
    In February 2021, MIG Fonds no.
  • In October 2021, MIG Capital led the 65 million euros Series B financing of biotech company iOmx Therapeutics with MIG Fond 16.
  • In 2021, MIG Fonds and its co-investors raised a total of around 275 million euros for MIG portfolio companies (previous year: 170 million euros).

DGAP-News: Compleo Charging Solutions AG: Compleo lays cornerstone for European market leadership and leap in sales to more than half a billion euros in 2025

Retrieved on: 
Friday, April 1, 2022
EBITDA, Letter, CET, Aldi, Federal Ministry of Finance (Germany), Group, Frankfurt Stock Exchange, Growth, Calibration, Software as a service, Gesellschaft mit beschränkter Haftung, Supermarket, Financial Oversight and Management Board for Puerto Rico v. Aurelius Investment, LLC, DC, Transport, Data infrastructure, Solution, Capital market, Software, AC Propulsion eBox, ISIN, Publication, Technology, Safety, AC, Depreciation, Time, Federal Ministry of Transport and Digital Infrastructure, Tax, Mark (given name), Daimler, Ebox, Lists of power stations, E.ON, Maintenance, EUR, Acquisition, Online shopping, Rail transport, Film, Service

Dortmund, March 25, 2022 - Based on preliminary, unaudited figures, Compleo Charging Solutions AG ("Compleo"), a leading European full-service provider of charging technologies, achieved total sales of EUR 57.5 million at Group level (2020: EUR 33.1 million).

Key Points: 
  • Dortmund, March 25, 2022 - Based on preliminary, unaudited figures, Compleo Charging Solutions AG ("Compleo"), a leading European full-service provider of charging technologies, achieved total sales of EUR 57.5 million at Group level (2020: EUR 33.1 million).
  • Compleo thus met its most recent sales forecast and continued to record steady growth in the past fiscal year.
  • With the approval of charging stations compliant with calibration laws in Austria, Compleo also sent a significant signal for the emerging European e-mobility industry.
  • DC charging stations from Compleo are the first DC charging stations on the market that comply with calibration regulations.

DGAP-News: Biotest AG: Biotest exceeds sales guidance in fiscal year 2021

Retrieved on: 
Friday, April 1, 2022
Plasma, Population, Therapy, VIII, EBT, Federal Ministry of Finance (Germany), III, Factor VIII, Marketing, Growth, Patient, Research, Next Level, Paul Ehrlich Institute, Board of directors, Czech Republic, EBIT, Federal Executive Boards, Tax, COVID-19, EAT, Annual report, Education, Acquisition, Security (finance), Fine chemical, Pharmaceutical industry, Health, Grifols

In fiscal year 2021, the Biotest Group generated revenues of 515.6 million, compared to 484.2 million in the previous year.

Key Points: 
  • In fiscal year 2021, the Biotest Group generated revenues of 515.6 million, compared to 484.2 million in the previous year.
  • This result is a consequence of growth in key sales markets due to the positive sales development of the main product Intratect(R).
  • EBIT amounted to - 47.1 million in fiscal 2021, compared to - 1.3 million in the previous year.
  • The Biotest Group's loss (EAT) for the financial year 2021 was - 63.4 million, compared to - 31.4 million in 2020.

DGAP-News: Austria: EQS Group new market leader for disclosure obligations and with strong customer growth in whistleblowing systems

Retrieved on: 
Wednesday, February 9, 2022
Erste Group, Growth, Disclosure, Financial Oversight and Management Board for Puerto Rico, APA, Solution, EQS, Compliance, OMV, Federal Ministry of Finance (Germany), Group, City, Regulatory technology, Justice, Public sector, Security (finance), Bottled water

Following the termination of the euro-adhoc service from APA-OTS, most customers who previously used this service have now switched over to EQS Group.

Key Points: 
  • Following the termination of the euro-adhoc service from APA-OTS, most customers who previously used this service have now switched over to EQS Group.
  • This means that EQS is now the market leader for disclosure obligations service in Austria; prior to this, the RegTech company was already leading cloud provider for whistleblowing systems by a wide margin.
  • When it comes to the investor relations division, EQS Group supports companies from all stock exchange segments, including 75% of all issuers on the Prime Market.
  • EQS Group is perfectly positioned for further growth in Austria, also thanks to the strong increase in its customer numbers.

DGAP-News: Hypoport SE: Assessment of the funding stop for energy-efficient buildings, the higher risk buffer required from banks for residential mortgage loans and a potential change of policy on interest rates

Retrieved on: 
Wednesday, February 2, 2022
Growth, B2B, Government, Starpool, Solution, Insurance, SME, Sale, Federal Financial Supervisory Authority, Policy, BEG, SMART, Climate change, Group, Technology, REM, Efficiency, Housing, Population, Workforce, Economy, City, Federal, Negotiation, ECB, Compliance, Frankfurt Stock Exchange, Federal Ministry of Finance (Germany), Federal Ministry for Economic Affairs and Energy, National Association of Home Builders, Public housing, MDAX, Deutsch, Real estate, Renewable energy, Construction, Bank, Financial services, Financial adviser, EP Europace, KfW

In most cases, German banks will step in and guarantee the funding while applicants await a decision on their case.

Key Points: 
  • In most cases, German banks will step in and guarantee the funding while applicants await a decision on their case.
  • On this basis, Hypoport does not expect the funding of construction projects that are already in progress to be significantly impacted.
  • Hypoport therefore does not anticipate material changes in the growth rates of its platform-based business models in the market for owner-occupied residential real estate.
  • Hypoport therefore believes that a potential change of policy on interest rates will have only minor implications for its business models in private mortgage finance.

Annual International Holocaust Survivors Night Celebrates Holocaust Survivors Around The World Tuesday, November 30, 2021

Retrieved on: 
Monday, November 29, 2021
Justice, Federal Ministry of Finance (Germany), Ministry of Diaspora Affairs, Yad Vashem, CEO, Conference, Wall, GMT, The Maccabeats, Festival, State, History, Museum, Family, EST, Hope, Social media, Friends, International Holocaust Remembrance Day, Survivor, Calendar, United States Holocaust Memorial Museum, Social equality, Light, Collegiate summer baseball, Darkness, ADL, Tourism

"In spite of the limitations from the global pandemic, we are committed to honoring Holocaust survivors every Chanukah, the Festival of Lights," said Gideon Taylor.

Key Points: 
  • "In spite of the limitations from the global pandemic, we are committed to honoring Holocaust survivors every Chanukah, the Festival of Lights," said Gideon Taylor.
  • This year, survivors will spread their own messages of hope and resilience at a time when we need it most."
  • Holocaust survivors live every day as monuments to the strength and resilience of the Jewish people.
  • International Holocaust Survivors Night has grown each year and now includes more than 15 countries across 6 continents.